Financial statements Apteka Eliksir
Balance sheet data of APTEKA ELIKSIR
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 479 030,55 | 384 342,38 | 347 463,55 | 427 047,10 | 397 431,10 |
| A. Fixed assets | 114 246,03 | 101 040,03 | 95 432,54 | 94 802,54 | 94 502,54 |
| B. Current assets | 364 784,52 | 283 302,35 | 252 031,01 | 332 244,56 | 302 928,56 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 479 030,55 | 384 342,38 | 347 463,55 | 427 047,10 | 397 431,10 |
| A. Equity | 179 417,42 | 190 829,73 | 203 512,43 | 263 788,50 | 211 753,38 |
| B. Liabilities and provisions for liabilities | 299 613,13 | 193 512,65 | 143 951,12 | 163 258,60 | 185 677,72 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 299 613,13 | 193 512,65 | 143 951,12 | 163 141,00 | 184 214,70 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.